http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014150435-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
filingDate 2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014150435-A
titleOfInvention GETTING AN ANTI-VIRUS COMPOUND
abstract 1. A method of obtaining a compound of formula I:, or a pharmaceutically acceptable salt thereof, comprising (A) a reaction of combining a compound of formula (i) with a compound of formula (ii) in the presence of a metal catalyst and a base to obtain a compound of formula (iii) or its salt :( B) deprotecting a compound of formula (iii) to give a compound of formula (iv): or a salt thereof; (C) contacting a compound of formula (iv) with (S) -2- (methoxycarbonylamino) -3-methylbutanoic acid: s obtaining the compounds of formula I; moreover, each of PG independently represents a protective group of an amino group; Y and Z are independently selected from Br and —B (OR) (OR ′), wherein when Y is —B (OR) (OR ′), then Z is Br and Y is Br, then Z is —B ( OR) (OR ′); and R and R ′ are independently selected from the group consisting of hydrogen and straight or branched C-alkyl, or R and R ′ together are straight or branched C-alkylene, C-cycloalkylene or C-arylene, wherein any alkyl, alkylene, cycloalkylene or arylene is optionally substituted with one or more substituents selected from the group consisting of C-alkyl, —C (O) N (C-alkyl), and —C (O) O (C-alkyl). 2. The method of claim 1, wherein Y is —B (OR) (OR ′) and Z is Br. 3. The method of claim 2, further comprising the step of forming the compound of formula (i) under in situ conditions, comprising sequentially bringing the compound of formula (a) into contact with a palladium source, and then with a boronating agent containing a group: in the presence of a second base, provided that the compound of formula (i) is formed in situ, and X is a halide selected from O, Br and I.4. The method according to p. 3, characterized in that the stage of formation of the compounds of formula (i) in situ and stage (A) are carried out in a single reactor
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2705809-C2
priorityDate 2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452747176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409448523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416158103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451339314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426166444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71310626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134355023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430273897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147953914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10942966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393653

Total number of triples: 45.